high-altitude pulmonary hypertension(English)

• affects individuals residing at altitudes of 2,500 meters and higher. Numerous pathogenic variables play a role in disease inception and progression and include low oxygen concentration in inspired air, vasculopathy, and metabolic abnormalities. Since HAPH affects only some people living at high altitude genetic factors play a significant role in its pathogenesis. The clinical presentation is nonspecific and includes fatigue, shortness of breath, cognitive deficits, cough, and in advanced cases hepatosplenomegaly and overt right-sided heart failure
• AMS, CMS, HACE, HAPE, PH, HPV
• Pulmonology, Hypertension, Cardiology
• https://doi.org…192401610010019